Hypometabolic Strategies in Caenorhabditis elegans: Conserved and Contrasting Signals with the Mammalian System
FULL TEXT PDF (ENGLISH)

Keywords

Hypometabolism, Lifespan extension, Diapause, Post-translational modification, Transcriptional regulation, Apoptosis

How to Cite

[1]
Benjamin Lant and Kenneth B. Storey trans. 2025. Hypometabolic Strategies in Caenorhabditis elegans: Conserved and Contrasting Signals with the Mammalian System. Food Additives and Contaminants. 42, 1 (Nov. 2025), 60–101. DOI:https://doi.org/10.5281/h5ntz264.

Abstract

Studies of the molecular mechanisms that are involved in stress responses (environmental or
physiological) have long been used to make links to disease states in humans. The nematode
model organism, Caenorhabditis elegans, undergoes a state of hypometabolism called the
‘dauer’ stage. This period of developmental arrest is characterized by a significant reduction
in metabolic rate, triggered by ambient temperature increase and restricted oxygen/ nutrients. C. elegans employs a number of signal transduction cascades in order to adapt to these
unfavourable conditions and survive for long times with severely reduced energy production.
The suppression of cellular metabolism, providing energetic homeostasis, is critical to the
survival of nematodes through the dauer period. This transition displays molecular mechanisms that are fundamental to control of hypometabolism across the animal kingdom. In
general, mammalian systems are highly inelastic to environmental stresses (such as extreme
temperatures and low oxygen), however, there is a great deal of conservation between the
signal transduction pathways of nematodes and mammals. Along with conserving many of the
protein targets in the stress response, many of the critical regulatory mechanisms are
maintained, and often differ only in their level of expression. Hence, the C. elegans model
outlines a framework of critical molecular mechanisms that may be employed in the future
as therapeutic targets for addressing disease states. 

FULL TEXT PDF (ENGLISH)

References

Yamashita O, and Hasegawa K. Embryonic diapause. In:

Kerkut G.A., Gilbert L.I., eds. Comprehensive Insect Physiology, Biochemistry and Pharmacology, vol. 1. Oxford: Pergamon

Press. 1985: 407–434.

2. Nakagaki M., Takei R., Nagashima E, and Yaginuma T. Cell

cycles in embryos of the silkworm, Bombyx mori: G2-arrest at

diapause stage. Roux’s Archives of Developmental Biology

1991; 200: 223–229.

3. MacRae T.H. Molecular chaperones, stress resistance and development in Artemia franciscana. Semin Cell Dev Biol. 2003;

14(5):251-258.

4. Renfree M.B, and Shaw G. Diapause. Annu Rev Physiol. 2000;

62: 353-375.

5. Lopes F.L., Desmarais J.A, and Murphy BD. Embryonic diapause and its regulation. Reproduction. 2004; 128(6): 669-678.

6. Storey K.B. Out cold: biochemical regulation of mammalian

hibernation. Gerontology. 2009; in press.

7. Hochachka P.W, and Lutz PL. Mechanism, Origin, and Evolution of Anoxia Tolerance in Animals. Comp Biochem Physiol B

2001; 130(4):435 – 459

8. Denlinger D.L. Regulation of Diapause. Annu Rev Entomol.

2002; 47:93 – 122.

9. Clegg J.S. Cryptobiosis – A Peculiar State of Biological Organization. Comp Biochem Physiol B. 2001; 128(4):613 – 24

10. Storey K.B. Life in the Slow Lane: Molecular Mechanisms of

Estivation. Comp Biochem Physiol A 2002; 133(3): 733 – 754

11. Storey K.B, and Storey JM. Metabolic Rate Depression and

Biochemical Adaptation in Anaerobiosis, Hibernation and Estivation. Quart Rev Biol. 1990; 65(2): 145 – 174

12. Storey K.B, and Storey JM. Metabolic Rate Depression in Animals: Transcriptional and Translational Control. Biol Rev Camb

Philos Soc. 2004; 79(1): 207 – 233

13. Heldmaier G., Ortmann S, and Elvert R. Natural Hypometabolism During Hibernation and Daily Torpor in Mammals. Respir

Physiol Neurobiol. 2004; 141(3): 317 – 329

14. Berk A.J. Regulation of Eukaryotic Transcription Factors by

Post-Translational Modification. Biochim Biophys Acta. 1989;

1009(2): 103 – 109

15. Johnson E.S. Protein Modification by SUMO. Annu Rev Biochem. 2004; 73: 355 – 382

16. Vanfleteren J.R, and Braeckman BP. Mechanisms of life span

determination in Caenorhabditis elegans. Neurobiol Aging.

1999; 20: 487 – 502

17. Burgering B.M.T, and Kops GJPL. Cell cycle and death control:

long live forkheads. Trends Biochem Sci. 2002; 27(7): 352-360

18. Beall M.J, and Pearce EJ. Transforming growth factor-beta and

insulin like signaling pathways in parasitic helminthes. Intl J

Parasit. 2002; 32: 399 – 404

19. Barbieri M., Bonafe M., Franceschi C, and Paolisso G. Insulin/IGF-I-Signaling Pathway: An Evolutionarily Conserved

Mechanism of Longevity from Yeast to Humans. Am J Physiol

2003; 285(5): E1064 – E1071

20. Ramnanan C.J., Groom A.G, and Storey KB. Akt and its Downstream Targets Play Key Roles in Mediating Dormancy in Land

Snails. Comp Biochem Physiol B. 2007; 148(2): 245 – 255

21. Osaki M., Oshimura M, and Ito H. PI3K-Akt Pathway: Its

Functions and Alterations in Human Cancer. Apoptosis. 2004;

9: 667 – 676

22. Jiang B.H, and Liu LZ. PI3K/PTEN signaling in Tumorigenesis

and Angiogenesis. Biochim Biophys Acta. 2008; 1784: 150 – 158

23. Tremblay M.L, and Giguere V. Phosphatases at the Heart of

FoxO Metabolic Control. Cell Metab. 2008; 7(2): 101 – 103

24. Lee R.Y.N., Hench J, and Ruvkun G. Regulation of C. elegans

DAF-16 and its human ortholog FKHRL1 by the Daf-2 insulin-like signaling pathway. Curr Biol 2001; 11: 1950-1957

25. Van der Horst A, and Burgering BM. Stressing the role of FoxO

Proteins in Lifespan and Disease. Nat Rev Mol Cell Biol. 2007;

8(6): 440 – 450

26. Obsilova V., Silhan J., Boura E., Teisinger J, and Obsil T. 14-3-3

Proteins: a Family of Versatile Molecular Regulators. Physiol

Res. 2008; 57(3): 11 – 21

27. Van Gorp A.C., Pomeranz K.M., Birkenkamp K.U., Hui R.C.,

Lam E.W, and Coffer PJ. Chronic Protein Kinase B (PKB/c-Akt)

Activation Leads to Apoptosis Induced by Oxidative

Stress-Mediated Foxo3a Transcriptional Up-Regulation. Cancer

Res. 2008; 66(22): 10760 – 10769

28. Proud C.G. Signaling to Translation: How Signal Transduction

Pathways Control the Protein Synthetic Machinery. Biochem J.

2007; 403(2): 217 – 234

29. Kotliarova S., Pastorino S., Kovell L.C., Kotliarov Y, Song H.,

Zhang W., Bailey R., Maric D., Zenklusen J.C., Lee J, and Fine

HA. Glycogen Synthase Kinase-3 Inhibition Induces Glioma

Cell Death Through c-MYC, Nuclear Factor-Kappa B, and

Glucose Regulation. Cancer Res. 2008; 68(16): 6643 – 6651

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Copyright (c) 2025 Food Additives and Contaminants